Description
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) acetate is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate produces a relapsing-remitting neurological disease with extensive plaque-like demyelination[1][2][3].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)–COVID-19-immunoregulation–C120H181N35O31S—Research Square Print. September 28th, 2022.|Acta Physiol. 2023 Apr 25.|Cell Death Dis. 2022 Sep 2;13(9):759.|Int Immunopharmacol. 2022 Jan 29;105:108566.-[1]Rich C, et, al. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol. 2004 May;34(5):1251-61.|[2]Slavin A, et, al. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. 1998;28(2):109-20.|[3]Giralt M, et, al. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG35-55 in the Mouse. Methods Mol Biol. 2018;1791:227-232.—-2642.00–99.82–OC(C(F)(F)F)=O.O=C([C@@H](N)CCSC)N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)CCCCN)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)CC2=CC=C(O)C=C2)=O)CC(C)C)=O)CC3=CNC=N3)=O)C(C)C)=O)C(C)C)=O)CCCNC(N)=N)=O)CO)=O)CC4=CC=CC=C4)=O)CCC1)=O)CO)=O)CCCNC(N)=N)=O)CC5=CC=C(O)C=C5)=O)CC6=CNC7=CC=CC=C67)=O)=O)C(C)C)=O)CCC(O)=O–Inflammation/Immunology; Neurological Disease–H2O : 100 mg/mL (ultrasonic)–Others—-Others–Peptides




Did you check our products for animal nutrition?